Integrating our knowledge on biological heterogeneity into clinical trial design, which has
revolutionized other medical fields, could serve as a solution to implement personalized …

Background The respective benefits of high and low doses of dexamethasone (DXM) in
patients with severe acute respiratory syndrome coronavirus 2 (SARS‑Cov2) and acute …

Of the many lessons to draw from the coronavirus disease 2019 (COVID-19) pandemic is the
need to implement precision medicine for critical illnesses without delay. COVID-19 was …

COVID-19-related acute respiratory distress syndrome (CARDS) has been suggested to
differ from the typical ARDS. While distinct phenotypes of ARDS have been identified …

Background In patients who experience out-of-hospital cardiac arrest (OHCA), it is important
to assess the association of sub-phenotypes identified by latent class analysis (LCA) using …

Objective We aim to identify the clinical phenotypes of immunocompromised patients with
pneumonia-related ARDS, to investigate the lung microbiota signatures and the outcomes of …

At the outset of the coronavirus disease (COVID-19) pandemic, some observers reported
differences between COVID-19 acute respiratory distress syndrome (ARDS) and non …

Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts
online as soon as possible after acceptance. Accepted manuscripts have been peer …

Background There is no predictive tool developed for pneumonia-associated acute
respiratory distress syndrome (ARDS) specifically so far, and the clinical risk classification of …

Background Refractory cardiogenic shock (CS) patients receiving venous-arterial
extracorporeal membrane oxygenation (VA-ECMO) have a wide range of mortality, machine …